keveyis
Generic: dichlorphenamide
keveyis: developed by 2 companies.
keveyis evidence translation
What we can confirm
No verified FDA or trial count is available.
What it means
More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Evidence is limited; missing information remains unknown.
BioSniper AIPage evidence connected
Prepared research question
What is verified about keveyis, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
hyperkalemic, hypokalemic, and related variants of primary periodic paralysisTreatment of hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis (PPP)
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Strongbridge Biopharma plc (SBBP) hyperkalemic, hypokalemic, and related variants of primary p… | Approved |
| Xeris Biopharma Holdings, Inc. (XERS) Treatment of hyperkalemic, hypokalemic, and related variants… | Approved |